A suspected plague death in Russia has renewed attention on the rare infection. Here's how to spot pneumonic plague and which antibiotics the CDC recommends.
|Articles|December 15, 2021
Daily Medication Pearl: Ondansetron Hydrochloride (Zofran)
Author(s)Saro Arakelians, PharmD
Zofran aids in the prevention of nausea and vomiting.
Advertisement
Medication Pearl of the Day: Ondansetron Hydrochloride (Zofran)
Indication: Zofran is a 5-HT3 receptor antagonist indicated for the prevention of nausea and vomiting.
Insight:
- Dosing: Take 1 tablet every day or as needed prescribed by the provider.
- Dosage forms: Tablets 4 mg and 8 mg (orally disintegrating tablets available), oral solution 4 mg/5 mL.
- Adverse events (AEs): The most common AEs in adults are headache, malaise/fatigue, constipation, and diarrhea.
- Mechanism of action: Ondansetron is a selective 5-HT3 receptor antagonist.
- Manufacturer: GSK
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
SubscribeAdvertisement
Related to this article
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
Investigational inhaled stem cells for COPD raise questions about lasting clinical benefit and the pharmacy controls needed to deliver a living-cell product through a nebulizer.
In an interview with Pharmacy Times, Abdulkader Rahmo, PhD, discusses investigational inhaled cell therapy for COPD, the evidence needed to establish lasting clinical benefit, and pharmacists’ potential role in its delivery.
A meta-analysis of 27 trials found 15% lower cardiovascular (CV) event risk per 10-mm Hg SBP reduction, with eGFR declines but no rise in kidney failure.
In an interview with Pharmacy Times, City of Hope researchers discuss a preclinical platform designed to redirect CAR T cells after infusion and how pharmacists could help bring this adaptable approach into clinical practice.
Pharmacists can explain the evidence supporting the intramuscular injection, address specific concerns, and help families understand what is known—and what is not known—about oral vitamin K.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Advertisement
Advertisement